Cyberonics is now LivaNova. Learn more here.

Investor Relations

Cyberonics and Sorin have merged and are now LivaNova. Information found here may no longer be correct or up-to-date; please visit for the most current information.
Your continued use of our website constitutes understanding and acceptance of these changes.


$ 69.95

0.86 (1.25%)

Day High: 70.25
Day Low:  68.66
Volume:    40,794

4:00 PM ET
Oct 16, 2015

Delayed at least 20 min., by eSignal.

Stock price graph

Cyberonics, Inc. (NASDAQ:CYBX) is a medical technology company with core expertise in neuromodulation. The company developed and markets the Vagus Nerve Stimulation (VNS) Therapy System, which is FDA-approved for the treatment of refractory epilepsy and treatment-resistant depression. The VNS Therapy System uses a surgically implanted medical device that delivers electrical pulsed signals to the vagus nerve. Cyberonics markets the VNS Therapy System in selected markets worldwide.

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Cyberonics, Inc.'s financial performance into perspective.

View all »   RSSRecent Releases

Oct 9, 2015
Sorin And Cyberonics Announce Appointment Of Remaining Post-Merger Directors Of Combined Company

Sep 28, 2015
Extended Follow-Up Of ANTHEM-HF Patients Shows That Benefits Of Autonomic Regulation Therapy Are Maintained After 12 Months

Shareholder Tools                         

Contact Us

100 Cyberonics Boulevard
Houston, Texas USA 77058



Investor Relations




Transfer Agent Information

P.O. BOX 30170
College Station, TX 77842-3170

Overnight correspondence should be sent to:

211 Quality Circle, Suite 210
College Station, TX 77845

Shareholder website

Shareholder online inquiries

Proud Member MDMAAdvaMed: Code of ethics supporter

© Cyberonics, Inc. 2016 | All rights reserved.